A cohort study comparing the risk of fractures in Rheumatoid Arthritis patients who initiated TNFi versus other biologicals like Abatacept and Tocilizumab in South Korea
Latest Information Update: 03 Mar 2021
At a glance
- Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 03 Mar 2021 New trial record